Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation

Bart Roelf Jan van Dijken; A. van der Hoorn

doi:10.1007/s00330-020-07588-w

Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation

Bart Roelf Jan van Dijken^*, A. van der Hoorn

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

2 Citations (Scopus)

59 Downloads (Pure)

Original language	English
Number of pages	2
Journal	European Radiology
Early online date	11-Jan-2021
DOIs	https://doi.org/10.1007/s00330-020-07588-w
Publication status	Published - 11-Jan-2021

Keywords

TEMOZOLOMIDE

Access to Document

10.1007/s00330-020-07588-w

Radiology in the lead towards radiological profiling for precision medicine in glioblastoma patients Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylationFinal publisher's version, 149 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{ca4be41eb6644ab3af6ee5730cb392b8,

title = "Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation",

keywords = "TEMOZOLOMIDE",

author = "{van Dijken}, {Bart Roelf Jan} and {van der Hoorn}, A.",

year = "2021",

month = jan,

day = "11",

doi = "10.1007/s00330-020-07588-w",

language = "English",

journal = "European Radiology",

issn = "0938-7994",

publisher = "Springer",

}

Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation. / van Dijken, Bart Roelf Jan ; van der Hoorn, A.
In: European Radiology, 11.01.2021.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Radiology in the lead

T2 - towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation

AU - van Dijken, Bart Roelf Jan

AU - van der Hoorn, A.

PY - 2021/1/11

Y1 - 2021/1/11

KW - TEMOZOLOMIDE

U2 - 10.1007/s00330-020-07588-w

DO - 10.1007/s00330-020-07588-w

M3 - Editorial

C2 - 33427947

SN - 0938-7994

JO - European Radiology

JF - European Radiology

ER -